Answers are grounded in this paper and cite their sources.
Bone regeneration in oral and craniofacial defects requires biomaterials that provide structural support while promoting osteoblast activity. Chitosan-based hydrogels are widely investigated due to their biocompatibility and tunable physicochemical properties; however, the influence of chitosan molecular weight on the biological performance of gelatin/platelet-rich fibrin (PRF) composite scaffolds remains insufficiently defined. This study aimed to determine whether low-molecular-weight chitosan enhances osteoblast viability and metabolic activity relative to high-molecular-weight chitosan by promoting a more porous and rapidly degrading gelatin/PRF scaffold architecture. We fabricated gelatin/PRF hydrogels incorporating low- or high-molecular-weight chitosan at different concentrations by freeze-drying. We analyzed swelling behavior, degradation kinetics, and porous microarchitecture, and assessed in vitro biocompatibility using human SaOS-2 osteoblastic cells via MTS and Live/Dead assays. Hydrogels formulated with 3% low-molecular-weight chitosan exhibited highly interconnected pores (mean ∼93 μm) and controlled degradation (∼56% mass loss at 21 days). They supported osteoblast metabolic activity above control and showed higher early viability than the high-molecular-weight formulation. These findings demonstrate that chitosan molecular weight critically modulates scaffold microarchitecture and cellular response, supporting its potential application as a bioactive scaffold for oral and craniofacial bone regeneration.
No takes yet. Share an insight, caveat, or question.
Mercado-Pacheco et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: